More on: is laboratory monitoring of low-molecular-weight heparin necessary?
Shojania
A M
AM
D000293:Adolescent; D000925:Anticoagulants / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D002648:Child; D016903:Drug Monitoring; D015951:Factor Xa / Q000032:analysis; D065427:Factor Xa Inhibitors; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D013997:Time Factors
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight; D015951:Factor Xa